HOXB9 and cancer: This hypothesis is supported by findings from studies conducted in other types of cancer, showing that HOXB9 knockdown results in cell-cycle arrest, indicating that it may be an important molecular component of the cell cycle and may be a promising target for novel personalised gene therapy [38].